Target intelligence / Profile preview

Off-target mRNAs with partial complementarity to shRNA-SON guide strand

Molecular classification
Messenger RNA
01

Overview

Off-target mRNAs with partial complementarity to the shRNA-SON guide strand refers to a population of unintended cellular transcripts that are suppressed during RNA interference (RNAi) experiments targeting the SON DNA binding protein. This phenomenon, known as miRNA-like off-targeting, occurs when the guide strand of an shRNA possesses a seed sequence (nucleotides 2-8) that is complementary to the 3' untranslated regions (UTRs) of non-target mRNAs (Jackson et al., 2003, Nature Biotechnology). Because the SON protein is a master regulator of RNA splicing and cell cycle progression, particularly in hematopoietic and leukemic cells, shRNA-mediated knockdown is a common research tool; however, the resulting off-target effects can confound experimental data by inducing phenotypes unrelated to SON depletion (Ahn et al., 2011, Molecular Cell). These off-target interactions are a major concern in the development of RNAi-based therapeutics, as they can lead to unintended toxicity and reduced therapeutic index (Birmingham et al., 2006, Nature Methods). Consequently, identifying and mitigating these interactions through advanced computational design and transcriptomic validation is essential for ensuring the specificity of gene-silencing interventions. In the specific case of shRNA-SON, these off-targets represent any cellular mRNA possessing sequences complementary to the SON-specific guide strand's seed sequence, potentially leading to widespread and unpredictable changes in the cellular proteome.

Other names
shRNA-mediated off-target transcriptsmiRNA-like off-targets of shRNA-SONSeed-matched off-targets
02

Mechanism of action

Unintended gene silencing via RISC-mediated mRNA degradation or translational inhibition driven by partial sequence complementarity, typically involving the seed region of the guide strand.

03

Biological functions

Protein synthesisGene expression regulation
04

Disease associations

Other
05

Safety considerations

Off-target toxicityConfounding experimental resultsUnintended downregulation of essential genesSaturation of the RNAi machinery
06

Interacting drugs

shRNA-SON
07

Biomarkers

RNA-seq transcriptomic profileSeed-sequence enrichment analysis

Beyond the preview

Go deeper on Off-target mRNAs with partial complementarity to shRNA-SON guide strand.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Off-target mRNAs with partial complementarity to shRNA-SON guide strand.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call